Skip to content
Recinto de Ciencias MédicasUPR787-758-2525Paseo Dr. Jose Celso Barbosa, San Juan, 00921
Facebook page opens in new windowX page opens in new windowInstagram page opens in new windowYouTube page opens in new window
Search:
Institutional Review Board
Institutional Review Board
  • Home
  • Resources
    • Calendars
    • IRB Fees
    • CITI Program
      • CITI Instructions
      • Carta Good Clinical Practice
    • Certifications
      • Certification 45 2006 2007 Scientific Misconduct
      • Certificacion 8 Conflict of Interest 2012_2013
      • Federal Wide Assurance (FWA) Certification (July 12, 2029)
      • Chancellor Letter (Spanish)
    • Templates (consents, assent & informative sheet)
      • Informed Consent
        • Informed Consent Document (English New Version)
        • Consentimiento Informado (Spanish – New Version)
        • Informed Consent Form Reference Information
        • FORMULARIO DE CONSENTIMIENTO PARA INFORMES DE CASOS
        • CONSENT FORM FOR CASE REPORTS
      • Formulario de Asentimiento
      • Modelo de Hoja Informativa
      • Research Proposal Outline
      • Crisis Management Plan
      • Checklist to confirm that the submission is complete
    • Forms
      • HIPAA-use of identifiers
      • Request for Waiver of Authorization for the Release of Information
      • Formulario para candidatos para los comités de IRB
      • Adverse Event / Unanticipated Problem Report
      • IRB Authorization Agreement
      • Application for an External Institution to Serve as IRB of Record
      • Instructions to Request that an External Institution to Serve as IRB of Record
      • Solicitud Hoja de Prensa
    • Reference Documents
      • Manuals and Training Materials
        • UPR MSC IRB Manuals For Investigators
      • NIH Definition of Clinical Trial Decision Tree
      • Glosary of Clinical Trials Term
      • Lay Terms
      • Brochure
      • Guidance for Sponsors, Industry, Researchers, Investigators, and Food and Drug Administration Staff
    • Frequently Asked Questions (Spanish Version)
    • Useful Links
      • About Streamlyne
      • Go to Streamlyne
      • Western IRB
      • FDA
      • OHRP
      • Investigational New Drug (IND) Application
      • Citi Program
      • Advarra
  • Western IRB (WIRB)
    • Application to Submit Protocol to WIRB
    • WIRB Fees 2024
    • Informed Consent (WIRB/UPR)
    • WIRB Protocol Checklist
  • Streamlyne
    • About Streamlyne
    • How to Activate User Account
    • Streamlyne User Request Form
    • Go to Streamlyne
  • IRB Institutional Policies
    • Policies and Procedures
  • Contact
  • Home
  • Resources
    • Calendars
    • IRB Fees
    • CITI Program
      • CITI Instructions
      • Carta Good Clinical Practice
    • Certifications
      • Certification 45 2006 2007 Scientific Misconduct
      • Certificacion 8 Conflict of Interest 2012_2013
      • Federal Wide Assurance (FWA) Certification (July 12, 2029)
      • Chancellor Letter (Spanish)
    • Templates (consents, assent & informative sheet)
      • Informed Consent
        • Informed Consent Document (English New Version)
        • Consentimiento Informado (Spanish – New Version)
        • Informed Consent Form Reference Information
        • FORMULARIO DE CONSENTIMIENTO PARA INFORMES DE CASOS
        • CONSENT FORM FOR CASE REPORTS
      • Formulario de Asentimiento
      • Modelo de Hoja Informativa
      • Research Proposal Outline
      • Crisis Management Plan
      • Checklist to confirm that the submission is complete
    • Forms
      • HIPAA-use of identifiers
      • Request for Waiver of Authorization for the Release of Information
      • Formulario para candidatos para los comités de IRB
      • Adverse Event / Unanticipated Problem Report
      • IRB Authorization Agreement
      • Application for an External Institution to Serve as IRB of Record
      • Instructions to Request that an External Institution to Serve as IRB of Record
      • Solicitud Hoja de Prensa
    • Reference Documents
      • Manuals and Training Materials
        • UPR MSC IRB Manuals For Investigators
      • NIH Definition of Clinical Trial Decision Tree
      • Glosary of Clinical Trials Term
      • Lay Terms
      • Brochure
      • Guidance for Sponsors, Industry, Researchers, Investigators, and Food and Drug Administration Staff
    • Frequently Asked Questions (Spanish Version)
    • Useful Links
      • About Streamlyne
      • Go to Streamlyne
      • Western IRB
      • FDA
      • OHRP
      • Investigational New Drug (IND) Application
      • Citi Program
      • Advarra
  • Western IRB (WIRB)
    • Application to Submit Protocol to WIRB
    • WIRB Fees 2024
    • Informed Consent (WIRB/UPR)
    • WIRB Protocol Checklist
  • Streamlyne
    • About Streamlyne
    • How to Activate User Account
    • Streamlyne User Request Form
    • Go to Streamlyne
  • IRB Institutional Policies
    • Policies and Procedures
  • Contact

Policies and Procedures

You are here:
  1. Home
  2. Policies and Procedures
Icon

IRB Policies and Procedures

1 file(s) 2.89 MB
Download
    Institutional Review Board
    © 2025 Oficina de Sistemas de Información, UPR-RCM.
    • Home
    • Resources
      • Calendars
      • IRB Fees
      • CITI Program
        • CITI Instructions
        • Carta Good Clinical Practice
      • Certifications
        • Certification 45 2006 2007 Scientific Misconduct
        • Certificacion 8 Conflict of Interest 2012_2013
        • Federal Wide Assurance (FWA) Certification (July 12, 2029)
        • Chancellor Letter (Spanish)
      • Templates (consents, assent & informative sheet)
        • Informed Consent
          • Informed Consent Document (English New Version)
          • Consentimiento Informado (Spanish – New Version)
          • Informed Consent Form Reference Information
          • FORMULARIO DE CONSENTIMIENTO PARA INFORMES DE CASOS
          • CONSENT FORM FOR CASE REPORTS
        • Formulario de Asentimiento
        • Modelo de Hoja Informativa
        • Research Proposal Outline
        • Crisis Management Plan
        • Checklist to confirm that the submission is complete
      • Forms
        • HIPAA-use of identifiers
        • Request for Waiver of Authorization for the Release of Information
        • Formulario para candidatos para los comités de IRB
        • Adverse Event / Unanticipated Problem Report
        • IRB Authorization Agreement
        • Application for an External Institution to Serve as IRB of Record
        • Instructions to Request that an External Institution to Serve as IRB of Record
        • Solicitud Hoja de Prensa
      • Reference Documents
        • Manuals and Training Materials
          • UPR MSC IRB Manuals For Investigators
        • NIH Definition of Clinical Trial Decision Tree
        • Glosary of Clinical Trials Term
        • Lay Terms
        • Brochure
        • Guidance for Sponsors, Industry, Researchers, Investigators, and Food and Drug Administration Staff
      • Frequently Asked Questions (Spanish Version)
      • Useful Links
        • About Streamlyne
        • Go to Streamlyne
        • Western IRB
        • FDA
        • OHRP
        • Investigational New Drug (IND) Application
        • Citi Program
        • Advarra
    • Western IRB (WIRB)
      • Application to Submit Protocol to WIRB
      • WIRB Fees 2024
      • Informed Consent (WIRB/UPR)
      • WIRB Protocol Checklist
    • Streamlyne
      • About Streamlyne
      • How to Activate User Account
      • Streamlyne User Request Form
      • Go to Streamlyne
    • IRB Institutional Policies
      • Policies and Procedures
    • Contact
    Primary Menu

    El RCM tiene vigente la Licencia de Renovación de la Junta de Instituciones Postsecundarias y está acreditado por la MSCHE (Middle States Commission on Higher Education). Además, no discrimina por raza, religión, sexo, nacionalidad, edad, origen o condición social o económica, impedimento físico o mental, ni afiliación política.
    The Medical Sciences Campus holds a Postsecondary Institutions Board Renewal License and is accredited by the MSCHE (Middle States Commission on Higher Education).In addition, it does not discriminate based on race, religion, sex, nationality, age, origin or social or economic condition, physical or mental disability, or political affiliation.